Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs032220597
JPRN-jRCTs032220597
Recruiting
N/A

Efficacy and safety of poly acrylic acid-poly vinylpyrrolidone complexes for bleeding time after arterial venous fistula decannulation in hemodialysis patients - PAA-PVP trial

Yamamoto Suguru0 sites50 target enrollmentJanuary 31, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Yamamoto Suguru
Enrollment
50
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yamamoto Suguru

Eligibility Criteria

Inclusion Criteria

  • •Patients who meet all the inclusion criteria as below,
  • •1\. Patients who can obtain written informed consent to participate in this study based on their free will.
  • •2\. Patients who are more than 18 years old.
  • •3\. Patients undergoing regular hemodialysis treatment 3 times a week and for 3\-5 hours each session using internal shunt.
  • •4\. Patients who use heparin as anti\-coagulant for hemodialysis treatment
  • •5\. Patients whose bleeding time after decannulation at the end of hemodialysis treatment is 10 minutes using regular hemostasis pad and band.

Exclusion Criteria

  • •Patients who meet any exclusion criteria as below.
  • •1\. Patients who participate in other clinical studies.
  • •2\. Patients who are pregnant or want pregnancy.
  • •3\. Patients who do not use internal shunt as vascular access.
  • •4\. Patients who use fingers or use band for more than 10 minutes for hemostasis after decannulation at the end of hemodialysis treatment.
  • •5\. Patients who have serious skin disease.
  • •6\. Patients who have the plan to start anti\-coagulant/anti\-platelet therapy
  • •7\. Patients that the investigators decide inappropriate to join the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Evaluation of the efficacy and safety of AVANZ® Phleum pratense in grass pollen-induced allergic rhinitis during controlled exposure in an environmental challenge chamberSeasonal grass pollen induced allergic rhino-conjunctivitis with or without asthma.MedDRA version: 17.0Level: LLTClassification code 10001728Term: Allergic rhinoconjunctivitisSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2013-005130-38-DEALK-Abello A/S
Not Yet Recruiting
Phase 3
To find out which is better glue or PVA particles in bronchial artery embolization in different bronchial vascular anatomies.
CTRI/2023/10/059286Datta Meghe Institute of Medical Sciences
Completed
N/A
To find out effect and safety of polyethylene glycol and sodium hyaluronate in patient with dry eye disease
CTRI/2023/02/049510Pt BD Sharma PGIMS Rohtak50
Completed
Phase 3
se of plastic wrap in preterm and low birth weight infants to prevent hypothermia during transportHealth Condition 1: null- preterm and low birth weight infants transported to Surya Childrenâ??s Hospital NIC
CTRI/2014/02/004415Surya Childrens Hospital
Recruiting
Phase 3
Comparison of the effectiveness of Cyanoacrylate with Dentin bonding on the Rate of Changes in Tooth SensitivityDental Sensitivity.Other specified diseases of hard tissues of teethK03.89
IRCT20120220009088N4Islamic Azad University40